Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 758192 10.3389/fphar.2021.758192 Pharmacology Correction Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics Copaescu et al. Antimicrobial Cellular Cytotoxicity Copaescu Ana 1 * Choshi Phuti 2 Pedretti Sarah 3 Mouhtouris Effie 1 Peter Jonathan 2 3 Trubiano Jason A. 1 4 5 6 Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Ana Copaescu, ana.copaescu@gmail.com

This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology

 02 09 2021 2021 12 758192 13 08 2021 18 08 2021 Copyright © 2021 Copaescu, Choshi, Pedretti, Mouhtouris, Peter and Trubiano. 2021 Copaescu, Choshi, Pedretti, Mouhtouris, Peter and Trubiano

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics by Copaescu, A., Choshi, P., Pedretti, S., Mouhtouris, E., Peter, J., and Trubiano, J. A. (2021). Front. Pharmacol. 12:640012. doi: 10.3389/fphar.2021.640012 delayed hypersensitivity reaction drug allergy severe cutaneous adverse reaction t-cell enzyme link immunospot cytotoxicity flow cytoametry lactate dehydrogenase

In the original article, we mistakenly omitted a statement from the Funding section. The statement reads as follows: “JP receives financial support from National Institutes of Health, award K43TW011178-02; the EDCTP2 programme supported by the European Union, grant number TMA2017SF-1981 and the South African National Research Foundation (NRF). PC receives a PhD fellowship from the Fogarty HATTP program, funded by the National Institutes of Health, award D43 TW010559-01”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.